188 related articles for article (PubMed ID: 1894759)
1. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
2. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
4. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
5. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
Thadani U; Hamilton SF; Olson E; Anderson JL; Prasad R; Voyles W; Doyle R; Kirsten E; Teague SM
Am J Cardiol; 1987 Apr; 59(8):756-62. PubMed ID: 3825935
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
7. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
9. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
[TBL] [Abstract][Full Text] [Related]
10. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
[TBL] [Abstract][Full Text] [Related]
11. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
12. Induction and circumvention of nitrate tolerance applying different dosage intervals.
Silber S; Vogler AC; Krause KH; Vogel M; Theisen K
Am J Med; 1987 Nov; 83(5):860-70. PubMed ID: 3674093
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
[TBL] [Abstract][Full Text] [Related]
14. Enhanced effectiveness of combined sustained-release forms of isosorbide dinitrate and diltiazem for stable angina pectoris.
Lehmann G; Reiniger G; Haase HU; Rudolph W
Am J Cardiol; 1991 Oct; 68(10):983-90. PubMed ID: 1927938
[TBL] [Abstract][Full Text] [Related]
15. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
Thadani U; Prasad R; Hamilton SF; Voyles WF; Doyle R; Karpow SA; Reder R; Teague SM
Clin Pharmacol Ther; 1987 Jul; 42(1):58-65. PubMed ID: 3595067
[TBL] [Abstract][Full Text] [Related]
16. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
[TBL] [Abstract][Full Text] [Related]
17. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
Thadani U; Bittar N
Am J Cardiol; 1992 Aug; 70(3):286-92. PubMed ID: 1632390
[TBL] [Abstract][Full Text] [Related]
18. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Quyyumi AA; Crake T; Wright CM; Mockus LJ; Fox KM
Br Heart J; 1987 Jun; 57(6):505-11. PubMed ID: 3304367
[TBL] [Abstract][Full Text] [Related]
20. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
